FDA recall D-0159-2017

Burel Pharmaceuticals Inc · Class II · drug

Product

AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-314-10

Reason for recall

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-10-24
Report date
2016-12-07
Termination date
2017-08-14
Voluntary/Mandated
Voluntary: Firm initiated
Location
Richland, MS, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0159-2017